Summary

● In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.

● The company has poor fundamentals for a short-term investment strategy.


Strengths

● Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 63% by 2018.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.


Weaknesses

● Stock prices approach a strong long-term resistance in weekly data at EUR 16.84.

● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● Analysts covering the stock have recently lowered their earnings forecast.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.